Randomized Multicenter Phase II Trial of Irinotecan and...

Annals of Oncology 2012 / 09 Vol. 23

Randomized Multicenter Phase II Trial of Irinotecan and Bevacizumab as Neo-Adjuvant and Adjuvant to Temozolomide-Based Chemoradiation Versus Chemoradiation for Unresectable Glioblastoma (DEFINITIVE RESULTS OF THE TEMAVIR ANOCEF STUDY)

Chauffert, B., Feuvret, L., Bonnetain, F., Taillandier, L., Frappaz, D., Honnorat, J., Fabbro, M., Frenay, M., Durando, X., Tennevet, I., Guillamo, J.S., Tailla, H., Schott, R., Ghiringhelli, F., Camp
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
23
Journal:
Annals of Oncology
DOI:
10.1016/s0923-7534(20)34313-1
Date:
September, 2012
File:
PDF, 55 KB
2012
Conversion to is in progress
Conversion to is failed